nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

23.11.2016 | Original Article

Healthy brain ageing assessed with 18F-FDG PET and age-dependent recovery factors after partial volume effect correction

verfasst von: Stijn Bonte, Pieter Vandemaele, Stijn Verleden, Kurt Audenaert, Karel Deblaere, Ingeborg Goethals, Roel Van Holen

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Excerpt

With the advent of positron emission tomography (PET) the brain metabolism can be mapped through detection of a glucose analogue radiotracer. This has proven to be a great tool in the expansion of our knowledge on brain function. However, the way in which the brain grows old is still not entirely unravelled by the scientific community. A thorough understanding of ageing is of great importance in the discrimination of the normal from the pathological brain. …

Nur mit Berechtigung zugänglich

Chételat G, Landeau B, Salmon E, et al. Relationships between brain metabolism decrease in normal aging and changes in structural and functional connectivity. Neuroimage 2013;76:167–77.CrossRefPubMed

Zuendorf G, Kerrouche N, Herholz K, Baron J-C. Efficient principal component analysis for multivariate 3D voxel-based mapping of brain functional imaging data sets as applied to FDG-PET and normal aging. Human Brain Mapping 2003;18(1):13–21.CrossRefPubMed

Moeller JR, Ishikawa T, Dhawan V, et al. The metabolic topography of normal aging. Journal of Cerebral Blood Flow and Metabolism 1996;16(3):385–98.CrossRefPubMed

Petit-Taboué MC, Landeau B, Desson JF, et al. Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping. Neuroimage 1998;7(3):176–84.CrossRefPubMed

Hsieh T-C, Lin W-Y, Ding H-J, et al. Sex-and Age-Related Differences in Brain FDG Metabolism of Healthy Adults: An SPM Analysis. Journal of Neuroimaging 2012;22(1):21–7.CrossRefPubMed

Willis M W, Ketter T A, Kimbrell T A, et al. Age sex and laterality effects on cerebral glucose metabolism in healthy adults. Psychiatry Research: Neuroimaging 2002;114(1):23–37.CrossRefPubMed

Fujimoto T, Matsumoto T, Fujita S, et al. Changes in glucose metabolism due to aging and gender-related differences in the healthy human brain. Psychiatry Research: Neuroimaging 2008;164(1):58–72.CrossRefPubMed

Yoshizawa H, Gazes Y, Stern Y, et al. Characterizing the normative profile of 18F-FDG PET brain imaging: Sex difference aging effect and cognitive reserve. Psychiatry Research: Neuroimaging 2014;221(1):78–85.CrossRefPubMed

Loessner A, Alavi A, Lewandrowski KU, et al. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. Journal of Nuclear Medicine 1995;36(7):1141–9.PubMed

10.

Shen X, Liu H, Hu Z, et al. The relationship between cerebral glucose metabolism and age: report of a large brain PET data set. PloS One 2012;7(12):e51517.CrossRefPubMedPubMedCentral

11.

Iseki E, Murayama N, Yamamoto R, et al. Construction of a 18F-FDG PET normative database of Japanese healthy elderly subjects and its application to demented and mild cognitive impairment patients. International Journal of Geriatric Psychiatry 2010;25(4):352–61.CrossRefPubMed

12.

Kim I-J, Kim S-J, Kim Y-K. Age-and sex-associated changes in cerebral glucose metabolism in normal healthy subjects: statistical parametric mapping analysis of F-18 fluorodeoxyglucose brain positron emission tomography. Acta Radiologica 2009;50(10):1169–74.CrossRefPubMed

13.

Kochunov P, Mangin J-F, Coyle T, et al. Age-related morphology trends of cortical sulci. Human Brain Mapping 2005;26(3):210–20.CrossRefPubMed

14.

Murphy D GM, DeCarli C, Schapiro M B, et al. Age-related differences in volumes of subcortical nuclei brain matter and cerebrospinal fluid in healthy men as measured with magnetic resonance imaging. Archives of Neurology 1992;49(8):839–45.CrossRefPubMed

15.

Ge Y, Grossman R I, Babb J S, Rabin M L, Mannon L J, et al. Age-related total gray matter and white matter changes in normal adult brain. Part I: volumetric MR imaging analysis. American Journal of Neuroradiology 2002;23(8):1327–33.PubMed

16.

Soret M, Bacharach S L, Buvat I. Partial-volume effect in PET tumor imaging. Journal of Nuclear Medicine 2007;48(6):932– 45.CrossRefPubMed

17.

Matsuda H, Ohnishi T, Asada T, et al. Correction for partial-volume effects on brain perfusion SPECT in healthy men. Journal of Nuclear Medicine 2003;44(8):1243–52.PubMed

18.

Meltzer C C, Leal J P, Mayberg H S, et al. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. Journal of Computer Assisted Tomography 1990;14(4):561–70.CrossRefPubMed

19.

Müller-Gärtner H W, Links J M, Prince J L, et al. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. Journal of Cerebral Blood Flow and Metabolism 1992;12(4):571–83.CrossRefPubMed

20.

Quarantelli M, Berkouk K, Prinster A, et al. Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. Journal of Nuclear Medicine 2004;45(2):192–201.PubMed

21.

Park H-J, Lee J D, Chun J W, et al. Cortical surface-based analysis of 18F-FDG PET: measured metabolic abnormalities in schizophrenia are affected by cortical structural abnormalities. Neuroimage 2006;31(4): 1434–44.CrossRefPubMed

22.

Curiati PK, Tamashiro-Duran JH, Duran FLS, et al. Age-Related Metabolic Profiles in Cognitively Healthy Elders: Results from a Voxel-Based [18F] Fluorodeoxyglucose–Positron-Emission Tomography Study with Partial Volume Effects Correction. American Journal of Neuroradiology 2011;32(3):560–5.CrossRefPubMed

23.

Ibáñez V, Pietrini P, Furey M L, et al. Resting state brain glucose metabolism is not reduced in normotensive healthy men during aging after correction for brain atrophy. Brain Research Bulletin 2004;63(2):147–54.CrossRefPubMed

24.

Kochunov P, Ramage AE, Lancaster JL, et al. Loss of cerebral white matter structural integrity tracks the gray matter metabolic decline in normal aging. Neuroimage 2009;45(1):17–28.CrossRefPubMed

25.

Kalpouzos G, Chételat G, Baron J-C, et al. Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiology of Aging 2009;30(1):112–24.CrossRefPubMed

26.

De Leon MJ, Convit A, Wolf OT, et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F] fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET). Proceedings of the National Academy of Sciences 2001;98(19):10966–71.CrossRef

27.

Yanase D, Matsunari I, Yajima K, et al. Brain FDG PET study of normal aging in Japanese: effect of atrophy correction. European Journal of Nuclear Medicine and Molecular Imaging 2005;32(7):794–805.CrossRefPubMed

28.

Knopman D S, Jack C R, Wiste H J, et al. 18 F-fluorodeoxyglucose positron emission tomography aging and apolipoprotein E genotype in cognitively normal persons. Neurobiology of Aging 2014;35(9):2096–106.CrossRefPubMedPubMedCentral

29.

Nugent S, Tremblay S, Chen K W, et al. Brain glucose and acetoacetate metabolism: a comparison of young and older adults. Neurobiology of Aging 2014;35(6):1386–95.CrossRefPubMed

30.

Nugent S, Castellano C-A, Goffaux P, et al. Glucose hypometabolism is highly localized but lower cortical thickness and brain atrophy are widespread in cognitively normal older adults. American Journal of Physiology-Endocrinology and Metabolism 2014:ajpendo–00067.

31.

Rousset O G, Ma Y, Evans A C. Correction for partial volume effects in PET: principle and validation. Journal of Nuclear Medicine 1998;39(5):904–11.PubMed

32.

Thomas B A. 2012. Improved brain PET quantification using partial volume correction techniques. UCL (University College London).

33.

Folstein M F, Folstein S E, McHugh P R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975;12(3):189–98.CrossRefPubMed

34.

Andreasen N C, O’Leary D S, Cizadlo T, Arndt S, Rezai K, Watkins G L, et al. Remembering the past: two facets of episodic memory explored with positron emission tomography. American Journal of Psychiatry 1995;152(11):1576–85.CrossRefPubMed

35.

Daube-Witherspoon ME, Matej S, Karp JS, Lewitt RM. Application of the row action maximum likelihood algorithm with spherical basis functions to clinical PET imaging. IEEE Transactions on Nuclear Science 2001;48(1): 24–30.CrossRef

36.

Watson C C, Newport DMEC, Casey M E. 1996. Three-dimensional image reconstruction in radiology and nuclear medicine. Springer.

37.

Hammers A, Allom R, Koepp M J, et al. Three-dimensional maximum probability atlas of the human brain with particular reference to the temporal lobe. Human brain mapping 2003;19(4):224–47.CrossRefPubMed

38.

Zaidi H, Ruest T, Schoenahl F, Montandon M-L. Comparative assessment of statistical brain MR image segmentation algorithms and their impact on partial volume correction in PET. Neuroimage 2006;32(4):1591–607.CrossRefPubMed

39.

Hoetjes N J, van Velden F HP, Hoekstra O S, Hoekstra C J, Krak N C, Lammertsma A A, et al. Partial volume correction strategies for quantitative FDG PET in oncology. European journal of nuclear medicine and molecular imaging 2010;37(9):1679–87.CrossRefPubMedPubMedCentral

40.

Gutierrez D, Montandon M-L, Assal F, Allaoua M, Ratib O, Lövblad K-O, et al. Anatomically guided voxel-based partial volume effect correction in brain PET: impact of MRI segmentation. Computerized Medical Imaging and Graphics 2012;36(8):610–9.CrossRefPubMed

41.

Teo B-K, Seo Y, Bacharach S L, et al. Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data. Journal of Nuclear Medicine 2007;48(5):802–10.PubMed

42.

Borghammer P, Cumming P, Aanerud J, Gjedde A. Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson’s disease. Neuroimage 2009;45(2):249–57.CrossRefPubMed

43.

Dukart J, Mueller K, Horstmann A, Vogt B, Frisch S, Barthel H, et al. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. Neuroimage 2010;49 (2):1490–5.CrossRefPubMed

44.

Kushner M, Tobin M, Alavi A, Chawluk J, Rosen M, Fazekas F, et al. Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET. Journal of Nuclear Medicine 1987;28(11): 1667–70.PubMed

45.

Yakushev I, Landvogt C, Buchholz H-G, Fellgiebel A, Hammers A, Scheurich A, et al. Choice of reference area in studies of Alzheimer’s disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Research: Neuroimaging 2008;164(2):143–53.CrossRefPubMed

Titel: Healthy brain ageing assessed with 18F-FDG PET and age-dependent recovery factors after partial volume effect correction
verfasst von: Stijn Bonte
Pieter Vandemaele
Stijn Verleden
Kurt Audenaert
Karel Deblaere
Ingeborg Goethals
Roel Van Holen
Publikationsdatum: 23.11.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 5/2017
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-016-3569-0

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2017

Ken Hermann, Omgo E. Neiweg and Stephen P. Povoski (eds): Radioguided Surgery. Current Applications and Innovative Directions in Clinical Practice

Radiopharmaceuticals for therapy by F.F. (Russ) Knapp and Ashutosh Dash

Textural features of 18F-fluorodeoxyglucose positron emission tomography scanning in diagnosing aortic prosthetic graft infection

Andrea Ciarmiello and Luigi Mansi (eds): PET/CT and PET/MRI in neurology. SWOT analysis applied to hybrid imaging

Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers

Left ventricular function in response to dipyridamole stress: head-to-head comparison between 82Rubidium PET and 99mTc-sestamibi SPECT ECG-gated myocardial perfusion imaging